1. Academic Validation
  2. Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway

Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway

  • Biochem Biophys Res Commun. 2024 Jul 23:718:150085. doi: 10.1016/j.bbrc.2024.150085.
Jiayan Lu 1 Qixia Guo 1 Hui Zhao 2 Hua Liu 3
Affiliations

Affiliations

  • 1 Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, People's Republic of China; Department of Pulmonary and Critical Care Medicine, Rugao Boai Hospital, No. 468 Qingyu Road, Rugao Economic and Technological Development Zone, 226500, Jiangsu Province, People's Republic of China.
  • 2 Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, People's Republic of China.
  • 3 Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, People's Republic of China. Electronic address: rgryrc@163.com.
Abstract

Lung Cancer poses a significant threat globally, especially in China. This puts higher demands on the treatment methods and drugs for lung Cancer. Natural Plants provide valuable resources for the development of anti-cancer drugs. Hederagenin (Hed) is a triterpenoid compound extracted from ivy leaves and has anti-tumor activity against multifarious cancers, including lung Cancer. However, the regulatory mechanism of Hed in lung Cancer remains unclear. In this study, we used Hed to treat lung Cancer cells, and observed the effect of Hed on cell proliferation (including CCK-8 and colony formation experiments), Apoptosis (including flow cytometry and Apoptosis gene detection (Bax and Bcl-2)). The results showed that Hed induced lung Cancer cell death (inhibiting proliferation and promoting Apoptosis). Next, we performed bioinformatics analysis of the expression profile GSE186218 and found that Hed treatment significantly increased the expression of CHAC1 gene. CHAC1 is a ferroptosis-inducing gene. RT-qPCR detection of lung Cancer clinical tissues and related cell lines also showed that CHAC1 was lowly expressed in lung Cancer. Therefore, we knocked down and overexpressed CHAC1 in lung Cancer cells, respectively. Subsequently, cell phenotype experiments showed that down-regulating CHAC1 expression inhibited lung Cancer cell death (promoting proliferation and inhibiting Apoptosis); on the contrary, up-regulating CHAC1 expression promoted lung Cancer cell death. To further verify that Hed exerts anti-tumor effects in lung Cancer by promoting CHAC1 expression, we performed functional rescue experiments. The results showed that down-regulating CHAC1 expression reversed the promoting effect of Hed on lung Cancer cell death. Mechanistically, in vitro and in vivo experiments jointly demonstrated that Hed exerts anti-cancer effects by promoting CHAC1-induced Ferroptosis. In summary, our study further enriches the regulatory mechanism of Hed in lung Cancer.

Keywords

CHAC1; Cell death; Ferroptosis; Hederagenin; Lung cancer.

Figures
Products